Symbols / NOVN
NOVN Chart
About
No company description available for this symbol.
Fundamentals
Scroll to Statements| Sector | — | Industry | — | Market Cap | — |
| Enterprise Value | — | Income | — | Sales | — |
| Book/sh | — | Cash/sh | — | Dividend Yield | — |
| Payout | — | Employees | — | IPO | — |
| P/E | — | Forward P/E | — | PEG | — |
| P/S | — | P/B | — | P/C | — |
| EV/EBITDA | — | EV/Sales | — | Quick Ratio | — |
| Current Ratio | — | Debt/Eq | — | LT Debt/Eq | — |
| EPS (ttm) | — | EPS next Y | — | EPS Growth | — |
| Revenue Growth | — | Earnings | — | ROA | — |
| ROE | — | ROIC | — | Gross Margin | — |
| Oper. Margin | — | Profit Margin | — | Shs Outstand | — |
| Shs Float | — | Short Float | — | Short Ratio | — |
| Short Interest | — | 52W High | — | 52W Low | — |
| Beta | — | Avg Volume | — | Volume | — |
| Target Price | — | Recom | — | Prev Close | — |
| Price | — | Change | — |
Valuation Models
Price estimates from analyst targets and simple models.
1. Analyst consensus
—
Mean price target
2. Current target
—
Latest analyst target
3. DCF / Fair value
—
Simplified FCF or EPS-based estimate
Ratings
No analyst ratings or price targets available.
- NOVN.SW Novartis (SIX) at CHF126.48 intraday 24 Feb 2026: watch pipeline catalysts - Meyka ue, 24 Feb 2026 14
- Assessing Novartis (SWX:NOVN) Valuation After Recent Share Price Momentum And Mixed Fair Value Signals - simplywall.st Mon, 23 Feb 2026 07
- Novartis AG (VTX:NOVN) Just Reported Full-Year Earnings: Have Analysts Changed Their Mind On The Stock? - Yahoo Finance Sat, 07 Feb 2026 08
- Novartis Stock Forecast: What’s Driving NOVN and Where It Could Go Next - TIKR.com Fri, 24 Oct 2025 07
- Is Novartis (SWX:NOVN) Attractive After Strong Multi Year Share Price Performance - Yahoo Finance Sat, 31 Jan 2026 08
- NOVN.SW Novartis (SIX) closed CHF126.48 19 Feb 2026: remibrutinib supports outlook - Meyka hu, 19 Feb 2026 19
- Is It Too Late To Consider Novartis (SWX:NOVN) After A 1-Year 35% Rally? - simplywall.st hu, 19 Feb 2026 21
- Novartis (SWX:NOVN): Exploring Whether the Recent Share Momentum Signals a Fair or Discounted Valuation - Yahoo Finance ue, 11 Nov 2025 08
- Pre-market Most Active: NOVN.SW Novartis (SIX) CHF123.80 13 Feb 2026: Watch upside - Meyka hu, 12 Feb 2026 23
- Is It Too Late To Consider Novartis (SWX:NOVN) After Strong Multi‑Year Share Price Gains? - simplywall.st Wed, 11 Feb 2026 08
- Is It Time To Reconsider Novartis (SWX:NOVN) After Its Recent Share Price Gains? - Yahoo Finance Sat, 10 Jan 2026 08
- CHF116.52 pre-market: Novartis AG (NOVN.SW) on SIX 28 Jan 2026 watch earnings - Meyka Wed, 28 Jan 2026 08
- Novartis (SWX:NOVN): Are Renal Bets And Radiopharmaceuticals Quietly Reshaping Its Long-Term Growth Mix? - simplywall.st Wed, 18 Feb 2026 07
- Assessing Novartis (SWX:NOVN) Valuation After Recent Share Price Momentum - Yahoo Finance Fri, 23 Jan 2026 08
- NOVN.SW Stock Today: February 05 — Q4 Sales Miss, Weak 2026 Outlook - Meyka hu, 05 Feb 2026 08
Insider Transactions
No recent insider transactions.
Financials
No financial statements available. Data is sourced from Yahoo Finance and cached; historical storage may be added later.
SEC Filings
No SEC filings found for this symbol (may be non-US or ticker not in SEC index).
Public Trades for NOVN
| Date | User | Asset | Broker | Type | Position Size | Entry Price | Patterns |
|---|